BIRC5 and breast carcinoma: They found that patients with survivin expression had lower overall survival.[33] Brennan et al used IHC and tissue microarray method to evaluate nuclear and cytoplasmic survivin expression by IHC in 102 breast cancer patients, who underwent surgery.